ADVERTISEMENT
ADVERTISEMENT

pembrolizumab

Immune Therapy Improves Lung Cancer Patientsā€™ Survival
Jim Daley | Apr 16, 2018 | 2 min read
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
ADVERTISEMENT